Abstract
Immunological ReviewsVolume 153, Issue 1 p. 5-26 The Role of B7-1/B7-2:CD28/CLTA-4 Pathways in the Prevention of Anergy, Induction of Productive Immunity and Down-Regulation of the Immune Response Vassiliki A. Boussiotis, Corresponding Author Vassiliki A. Boussiotis Division of Hematologic Malignancies, Dana Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.Vassiliki A. Boussiotis MD, PhD, Dana-Farber Cancer Institute, Dana 740,44 Binney Street, Boston, MA 02115, USA. Tel.:+1 617 632 4586. Fax: +1 617 632 5167.Search for more papers by this authorGordon J. Freeman, Gordon J. Freeman Division of Hematologic Malignancies, Dana Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.Search for more papers by this authorJohn G. Grffiben, John G. Grffiben Division of Hematologic Malignancies, Dana Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.Search for more papers by this authorLee M. Nadler, Lee M. Nadler Division of Hematologic Malignancies, Dana Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.Search for more papers by this author Vassiliki A. Boussiotis, Corresponding Author Vassiliki A. Boussiotis Division of Hematologic Malignancies, Dana Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.Vassiliki A. Boussiotis MD, PhD, Dana-Farber Cancer Institute, Dana 740,44 Binney Street, Boston, MA 02115, USA. Tel.:+1 617 632 4586. Fax: +1 617 632 5167.Search for more papers by this authorGordon J. Freeman, Gordon J. Freeman Division of Hematologic Malignancies, Dana Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.Search for more papers by this authorJohn G. Grffiben, John G. Grffiben Division of Hematologic Malignancies, Dana Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.Search for more papers by this authorLee M. Nadler, Lee M. Nadler Division of Hematologic Malignancies, Dana Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.Search for more papers by this author First published: October 1996 https://doi.org/10.1111/j.1600-065X.1996.tb00918.xCitations: 124AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Citing Literature Volume153, Issue1October 1996Pages 5-26 RelatedInformation
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
